Similar Search Results

Response to the expertise : procedures and methods of benefit assessments for medicines in Germany, by Geertruida E. Bekkering and Jos Kleijnen

Koch, Klaus; Lange, Stefan - In: The European journal of health economics : HEPAC ; … 10 (2009) 2, pp. 233-236

Persistent link: https://www.econbiz.de/10009522673

Early health economic evaluation of the future potential of next generation artificial vision systems for treating blindness in Germany

Schwander, Bjoern - In: Health economics review 4 (2014) 27, pp. 1-10

Germany. The innovative nature, the high unmet medical need and the expected unprecedented efficacy of next generation AVDs …

Persistent link: https://www.econbiz.de/10010526936

Comparative cost-effectiveness analysis of oral triptan therapy for migraine in four European countries

Hens, Manuel; Villaverde-Hueso, Ana; Alonso, Veronica; … - In: The European journal of health economics : HEPAC ; … 15 (2014) 4, pp. 433-437

Persistent link: https://www.econbiz.de/10010383394

Cost-effectiveness of extended-release niacin/laropiprant added to a stable simvastatin dose in secondary prevention patients not at cholesterol goal in Germany

Michailov, Galin V.; Davies, Glenn M.; Krobot, Karl J. - In: The European journal of health economics : HEPAC ; … 13 (2012) 3, pp. 365-374

Persistent link: https://www.econbiz.de/10010218882

Modeling the cost-effectiveness of infant vaccination with pneumococcal conjugate vaccines in Germany

Kuhlmann, Alexander; Schulenburg, Johann-Matthias von der - In: The European journal of health economics : HEPAC ; … 18 (2017) 3, pp. 273-292

Persistent link: https://www.econbiz.de/10011868215

Gesundheitsökonomie

Lüngen, Markus; Büscher, Guido - 2015 - 1. Auflage

Das Gesundheitswesen hat einerseits hohe Bedeutung für die Bürger und Patienten, andererseits ist es ein zunehmend bedeutsamer Wirtschaftsfaktor. Häufige Reformen und vielfältige Berichterstattung lassen den Eindruck entstehen, dass eine rationale Steuerung der gesundheitlichen Versorgung...